Cross-source evidence timeline

Avexitide research timeline

Follow 3 selected, directly cited source records from July 18, 2022 through August 24, 2026. This timeline joins source lanes for navigation; it does not infer that one record confirms another.

3Selected records
3Source years
1Evidence lanes
August 24, 2026Latest source date

Source year

2026

1 record
  1. Clinical trials

    ClinicalTrials.gov record NCT06747468↗

    PeptideScanner retained ClinicalTrials.gov record NCT06747468 at 2026-11-16T01:46:44.871Z. Its registry update date was 2026-08-24, and PeptideScanner's reviewed identity mapping was avexitide.↗

Source year

2023

1 record
  1. Clinical trials

    ClinicalTrials.gov record NCT04652479↗

    PeptideScanner retained ClinicalTrials.gov record NCT04652479 at 2026-11-16T01:46:44.871Z. Its registry update date was 2023-06-09, and PeptideScanner's reviewed identity mapping was avexitide.↗

Source year

2022

1 record
  1. Clinical trials

    ClinicalTrials.gov record NCT03373435↗

    PeptideScanner retained ClinicalTrials.gov record NCT03373435 at 2026-11-16T01:46:44.871Z. Its registry update date was 2022-07-18, and PeptideScanner's reviewed identity mapping was avexitide.↗